Mietrex TM 250mg/31.25mg Injection
Marketer
Mits Healthcare Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Mietrex TM 250mg/31.25mg Injection
Combiflox 250mg/31.25mg Injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus curbing infection spread. Administration must be strictly under a physician's guidance; adherence to the prescribed dosage schedule is crucial. Complete the full course of treatment, regardless of symptom improvement; premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or worsening side effects necessitate immediate medical attention. Seek emergency care for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your doctor of all current medications, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, nutritious food, and hydration are vital for optimal recovery. Your physician may order laboratory tests to monitor treatment response.
Uses of Mietrex TM 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Mietrex TM 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Mietrex TM 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Mietrex TM 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Mietrex TM 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam Injection (Mietrex™ 250mg/31.25mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their growth and survival. Tazobactam counteracts bacterial resistance mechanisms, thus boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Mietrex™ 250mg/31.25mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Mietrex TM, 250mg/31.25mg, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Mietrex™ 250mg/31.25mg Injection necessitates careful consideration during lactation. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administering Mietrex™ 250mg/31.25mg Injection could lead to drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Mietrex TM 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication Mietrex TM (250mg/31.25mg) requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Mietrex TM (250mg/31.25mg) injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Mietrex TM 250mg/31.25mg Injection :
Omit a Mietrex TM 250mg/31.25mg Injection dose? Seek your physician's advice.
Facts to Know About Mietrex TM 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently